Assist. Prof. Klemen Dovc, MD, PHD. Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children’s Hospital, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Klemen Dovc is an attending pediatric endocrinologist at the University Children’s Hospital Ljubljana, Slovenia. His research focus is on all aspects of new insulins, automated insulin delivery and continuous glucose monitoring. He collaborates on several publicly funded research projects, including an NIH grant and an EU Commission grant. His clinical and scientific activities focus on diabetes management with state-of-the-art technology, particularly artificial pancreas glucose control. Under the mentorship of prof. Tadej Battelino he completed his PhD with a thesis investigating closed-loop insulin delivery during and after physical activity and a Postdoctoral Clinical-Research Fellowship in Prof Hovorka’s group at the University of Cambridge,UK. As a member of DREAM consortium, he was involved in several in-patient and outpatient clinical trials with closed-loop insulin delivery. Dr Dovc performs voluntary activities in Slovene pediatric diabetes patients’ association “Sladkorčki”, is an active member of the national and international pediatric scientific communities and one of the co-founders of the ISPAD Young Researchers Community – the JENIOUS group, and he co-authored the section of the ISPAD Clinical Practice Consensus Guidelines. He is a member of EU Commission Expert panel on medical devices.

Presenter of 3 Presentations

First Evidence with the MiniMedTM 780G System and FiAsp in Adolescents: the FACT study

Session Type
Industry Symposium
Date
Thu, 28.04.2022
Session Time
10:30 - 12:00
Room
Hall 116
Lecture Time
11:14 - 11:29

Continuous and Intermittent Glucose Monitoring

Session Type
Plenary Session
Date
Fri, 29.04.2022
Session Time
13:00 - 14:30
Room
Hall 116
Lecture Time
14:18 - 14:24

Glucose control during exercise using automated insulin delivery in type 1 diabetes

Session Type
Parallel Session
Date
Thu, 28.04.2022
Session Time
16:40 - 18:00
Room
Hall 114
Lecture Time
17:40 - 18:00

Abstract

Abstract Body

While the benefits of regular physical activity are well established for individuals with type 1 diabetes, glucose control remains a challenge with conventional therapeutic tools, especially during and after physical activity. Factors affecting glycemic control include activity type (aerobic, anaerobic or mixed), intensity and duration of the activity, level of hydration, the secretion of counter-regulatory hormones as well as the amount of insulin and nutrients in the body, when the physical activity is performed.

Glucose-responsive automated insulin (and glucagon) delivery is now a routine clinical reality for many individuals living with type 1 diabetes. There are several automated insulin delivery systems are already available, at the same time there are several other devices extensively evaluated at home, mainly unsupervised, and for longer periods. The performance of automated insulin delivery devices has been challanged with different types of physical activity, using different exercise settings and duration, adding additional signals to detect physical activity, such as activity and heart rate monitoring, and including individuals with type 1 diabetes of different ages.

In this presentation, we will present current data on automated insulin delivery in type 1 diabetes challenged by physical activity.

Hide